NEURANICS LIMITED - Profile & Financials

Accounts Submitted 4 Jun 2025

Confirmation Statement Submitted 7 Aug 2025

Net assets £501.96K £534.65K 2024 year on year

Total assets £604.15K £588.17K 2024 year on year

Total Liabilities £102.19K £53.52K 2024 year on year

Charges None No charges registered

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

134 Douglas Street Rothesay House Glasgow G2 4HF Scotland

Credit Report

Discover NEURANICS LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2024

Type Total Exemption Full

Next accounts 31 December 2025

Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2022–2024)

Cash in Bank

£334.64k

Increased by £334.61k (+1079384%)

Net Assets

£501.96k

Increased by £534.65k (+1635%)

Total Liabilities

£102.19k

Increased by £53.52k (+110%)

Turnover

N/A

Employees

Debt Ratio

17%

Decreased by 288 (-94%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2024 Dec Year End	2023 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share allotments and capital structure

7 Allotments 2,683,487 Shares £8.33m Total

Date From	Share Class	Shares Allotted	Amount Raised	Price/Share
25 Apr 2025	A ORDINARY	175,127	£636k	£3.63
31 Mar 2025	A ORDINARY	1,306,626	£4.74m	£3.63
31 Mar 2025	A ORDINARY	206,611	£820k	£3.97
22 Nov 2024	ORDINARY	11,326	£7k	£0.6
8 Sept 2023	ORDINARY	752,317	£1.63m	£2.16

Officers

5 active 2 resigned

Show resigned officers

						Status
Hadi Heidari	Director	British	Scotland	42	14 Jul 2021	Active
Kianoush Nazarpour	Director	British	Scotland	45	7 Sept 2023	Active
Noel Mckenna	Director	British	Northern Ireland	56	7 Sept 2023	Active
Reuben Wilcock	Director	British	England	45	18 Jun 2025	Active
Ronan Anthony Cunningham	Director	Irish	Ireland	53	7 Sept 2023	Active

Shareholders

Shareholders (51)


William Leslie Robb	0.2%	6,886	A Ordinary	7 Aug 2025
William Savage	0.1%	3,305	A Ordinary	7 Aug 2025
Tony Mills	0.0%	1,377	A Ordinary	7 Aug 2025

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Kin Capital Partners Llp

United Kingdom

Active

Notified 8 Sept 2023

Nature of Control

Ownership Of Shares 25 To 50 Percent
Voting Rights 25 To 50 Percent

Hadi Heidari

Ceased 8 Sept 2023

Ceased

See All Controllers

Group Structure

KIN CAPITAL PARTNERS LLP united kingdom voting rights 75 to 100 percent limited liability partnership, right to share surplus assets 75 to 100 percent limited liability partnership, appoint/remove members limited liability partnership

KIN GROUP LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

BAND BIDCO LIMITED united kingdom

NEURANICS LIMITED Current Company

Charges

No charges registered

Documents

Company Filings

Date	Category	Description	Document
7 Aug 2025	Confirmation Statement	Confirmation statement made on 2025-07-13 with updates	View(8 pages)
18 Jun 2025	Officers	Appointment of Dr Reuben Wilcock as director on 2025-06-18	View(2 pages)
4 Jun 2025	Accounts	Annual accounts made up to 2024-12-31	View(8 pages)
30 Apr 2025	Capital	Allotment of shares (GBP 34.93247) on 2025-04-25	View(4 pages)
10 Apr 2025	Resolution	Resolutions	View(2 pages)